• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Impact of pegylated filgrastim in comparison to filgrastim for patients with acute myeloid leukaemia (AML) on high-dose cytarabine (HIDAC) consolidation chemotherapy.

作者信息

Kam Grace, Yiu Richard, Loh Yvonne, Ang Ai Leen, Yueh Ling Ling, Goh Yeow Tee, Wong Gee Chuan

机构信息

Department of Haematology, Singapore General Hospital, Outram Road, Singapore, 169608, Singapore,

出版信息

Support Care Cancer. 2015 Mar;23(3):643-9. doi: 10.1007/s00520-014-2417-7. Epub 2014 Aug 27.

DOI:10.1007/s00520-014-2417-7
PMID:25160495
Abstract
摘要

相似文献

1
Impact of pegylated filgrastim in comparison to filgrastim for patients with acute myeloid leukaemia (AML) on high-dose cytarabine (HIDAC) consolidation chemotherapy.聚乙二醇化非格司亭与非格司亭相比，对接受大剂量阿糖胞苷（HIDAC）巩固化疗的急性髓系白血病（AML）患者的影响。
Support Care Cancer. 2015 Mar;23(3):643-9. doi: 10.1007/s00520-014-2417-7. Epub 2014 Aug 27.
2
Intensive consolidation with G-CSF support: Tolerability, safety, reduced hospitalization, and efficacy in acute myeloid leukemia patients ≥60 years.在粒细胞集落刺激因子（G-CSF）支持下的强化巩固治疗：≥60岁急性髓系白血病患者的耐受性、安全性、住院时间缩短及疗效
Am J Hematol. 2017 Oct;92(10):E567-E574. doi: 10.1002/ajh.24847. Epub 2017 Aug 17.
3
A single dose of pegfilgrastim compared with daily filgrastim for supporting neutrophil recovery in patients treated for low-to-intermediate risk acute myeloid leukemia: results from a randomized, double-blind, phase 2 trial.单剂量培非格司亭与每日使用非格司亭用于支持低至中危急性髓系白血病患者中性粒细胞恢复的比较：一项随机、双盲、2期试验的结果
BMC Cancer. 2008 Jul 10;8:195. doi: 10.1186/1471-2407-8-195.
4
Neutropenia-associated outcomes in adults with acute myeloid leukemia receiving cytarabine consolidation chemotherapy with or without granulocyte colony-stimulating factor.中性粒细胞减少相关结局在接受阿糖胞苷巩固化疗联合或不联合粒细胞集落刺激因子的成人急性髓系白血病中的表现。
Pharmacotherapy. 2012 Dec;32(12):1070-7. doi: 10.1002/phar.1150.
5
Does High-Dose Cytarabine Cause More Fungal Infection in Patients With Acute Myeloid Leukemia Undergoing Consolidation Therapy: A Multicenter, Prospective, Observational Study in China.大剂量阿糖胞苷在接受巩固治疗的急性髓系白血病患者中是否会导致更多真菌感染：一项在中国进行的多中心、前瞻性、观察性研究。
Medicine (Baltimore). 2016 Jan;95(4):e2560. doi: 10.1097/MD.0000000000002560.
6
Impact of high dose cytarabine dosing strategies in obese patients with acute myeloid leukemia.肥胖急性髓系白血病患者中大剂量阿糖胞苷给药方案的影响。
Leuk Res. 2021 Mar;102:106517. doi: 10.1016/j.leukres.2021.106517. Epub 2021 Jan 26.
7
Efficacy and safety of consolidation therapy with intermediate and high dose cytarabine in acute myeloid leukemia patients.中高剂量阿糖胞苷巩固治疗急性髓系白血病患者的疗效和安全性。
Hematology. 2021 Dec;26(1):355-364. doi: 10.1080/16078454.2021.1912949.
8
Pegylated filgrastim is comparable with filgrastim as support for commonly used chemotherapy regimens: a multicenter, randomized, crossover phase 3 study.聚乙二醇化非格司亭与非格司亭作为常用化疗方案支持的疗效相当：一项多中心、随机、交叉 3 期研究。
Anticancer Drugs. 2013 Jul;24(6):641-7. doi: 10.1097/CAD.0b013e3283610b5d.
9
Dose-dense induction with sequential high-dose cytarabine and mitoxantone (S-HAM) and pegfilgrastim results in a high efficacy and a short duration of critical neutropenia in de novo acute myeloid leukemia: a pilot study of the AMLCG.序贯大剂量阿糖胞苷与米托蒽醌（S-HAM）及聚乙二醇化重组人粒细胞刺激因子进行剂量密集诱导治疗，在初治急性髓系白血病中疗效高且严重中性粒细胞减少持续时间短：一项德国急性髓系白血病协作组（AMLCG）的初步研究
Blood. 2009 Apr 23;113(17):3903-10. doi: 10.1182/blood-2008-07-162842. Epub 2009 Jan 8.
10
A randomized, multi-center, open-label, phase II study of once-per-cycle DA-3031, a biosimilar pegylated G-CSF, compared with daily filgrastim in patients receiving TAC chemotherapy for early-stage breast cancer.一项多中心、开放标签、随机对照 II 期研究，比较了每周期一次的 DA-3031（一种聚乙二醇化 G-CSF 生物类似药）与每日粒细胞集落刺激因子（filgrastim）在接受 TAC 化疗的早期乳腺癌患者中的应用。
Invest New Drugs. 2013 Oct;31(5):1300-6. doi: 10.1007/s10637-013-9973-4. Epub 2013 May 16.

引用本文的文献

1
Efficacy of delayed pegfilgrastim administration following consolidation therapy with high-dose cytarabine (HiDAC) in acute myeloid leukemia (AML) patients.在接受高剂量阿糖胞苷（HiDAC）巩固治疗的急性髓系白血病（AML）患者中，延迟使用培非格司亭的疗效。
Support Care Cancer. 2024 Apr 9;32(5):276. doi: 10.1007/s00520-024-08480-9.
2
[A single-center, randomized controlled trial of PEG-rhG-CSF and common rhG-CSF to promote neutrophil recovery after induction chemotherapy in newly diagnosed acute myeloid leukemia].[聚乙二醇化重组人粒细胞集落刺激因子与普通重组人粒细胞集落刺激因子促进新诊断急性髓系白血病诱导化疗后中性粒细胞恢复的单中心随机对照试验]
Zhonghua Xue Ye Xue Za Zhi. 2019 Jun 14;40(6):497-501. doi: 10.3760/cma.j.issn.0253-2727.2019.06.009.
3

本文引用的文献

1
Acute myeloid leukemia, version 2.2013.急性髓细胞白血病，2013 年版 2.0
J Natl Compr Canc Netw. 2013 Sep 1;11(9):1047-55. doi: 10.6004/jnccn.2013.0127.
2
Neutropenia-associated outcomes in adults with acute myeloid leukemia receiving cytarabine consolidation chemotherapy with or without granulocyte colony-stimulating factor.中性粒细胞减少相关结局在接受阿糖胞苷巩固化疗联合或不联合粒细胞集落刺激因子的成人急性髓系白血病中的表现。
Pharmacotherapy. 2012 Dec;32(12):1070-7. doi: 10.1002/phar.1150.
3
Cytarabine dose for acute myeloid leukemia.阿糖胞苷剂量治疗急性髓系白血病。
A phase I study of different doses and frequencies of pegylated recombinant human granulocyte-colony stimulating factor (PEG rhG-CSF) in patients with standard-dose chemotherapy-induced neutropenia.
一项针对标准剂量化疗所致中性粒细胞减少症患者的聚乙二醇化重组人粒细胞集落刺激因子（PEG rhG-CSF）不同剂量和给药频率的I期研究。
Chin J Cancer Res. 2017 Oct;29(5):402-410. doi: 10.21147/j.issn.1000-9604.2017.05.04.
4
Refining the role of pegfilgrastim (a long-acting G-CSF) for prevention of chemotherapy-induced febrile neutropenia: consensus guidance recommendations.优化聚乙二醇化重组人粒细胞刺激因子（长效粒细胞集落刺激因子）在预防化疗引起的发热性中性粒细胞减少症中的作用：共识性指导建议
Support Care Cancer. 2017 Nov;25(11):3295-3304. doi: 10.1007/s00520-017-3842-1. Epub 2017 Aug 25.
N Engl J Med. 2011 Mar 17;364(11):1027-36. doi: 10.1056/NEJMoa1010222.
4
Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america.抗菌药物在肿瘤中性粒细胞减少患者应用的临床实践指南：美国传染病学会 2010 年更新版。
Clin Infect Dis. 2011 Feb 15;52(4):e56-93. doi: 10.1093/cid/cir073.
5
A single dose pegfilgrastim for supporting neutrophil recovery in patients treated for high-risk acute myeloid leukemia by the EMA 2000 schedule.
Hematology. 2010 Jun;15(3):125-31. doi: 10.1179/102453309X12583347113654.
6
Dose-dense induction with sequential high-dose cytarabine and mitoxantone (S-HAM) and pegfilgrastim results in a high efficacy and a short duration of critical neutropenia in de novo acute myeloid leukemia: a pilot study of the AMLCG.序贯大剂量阿糖胞苷与米托蒽醌（S-HAM）及聚乙二醇化重组人粒细胞刺激因子进行剂量密集诱导治疗，在初治急性髓系白血病中疗效高且严重中性粒细胞减少持续时间短：一项德国急性髓系白血病协作组（AMLCG）的初步研究
Blood. 2009 Apr 23;113(17):3903-10. doi: 10.1182/blood-2008-07-162842. Epub 2009 Jan 8.
7
A single dose of pegfilgrastim compared with daily filgrastim for supporting neutrophil recovery in patients treated for low-to-intermediate risk acute myeloid leukemia: results from a randomized, double-blind, phase 2 trial.单剂量培非格司亭与每日使用非格司亭用于支持低至中危急性髓系白血病患者中性粒细胞恢复的比较：一项随机、双盲、2期试验的结果
BMC Cancer. 2008 Jul 10;8:195. doi: 10.1186/1471-2407-8-195.
8
Pegfilgrastim to support CHOP-14 in elderly patients with non-Hodgkin's lymphoma.
Leuk Lymphoma. 2006 Nov;47(11):2344-50. doi: 10.1080/10428190600881017.
9
Safety and efficacy of pegfilgrastim compared to granulocyte colony stimulating factor (G-CSF) supporting a dose-intensive, rapidly cycling anti-metabolite containing chemotherapy regimen (Hyper-CVAD) for lymphoid malignancy.与粒细胞集落刺激因子（G-CSF）相比，培非格司亭支持含剂量密集、快速循环抗代谢物的化疗方案（Hyper-CVAD）用于治疗淋巴系统恶性肿瘤的安全性和有效性。
Leuk Lymphoma. 2006 Sep;47(9):1813-7. doi: 10.1080/10428190600632832.
10
Pharmacokinetic/pharmacodynamic modeling of pegfilgrastim in healthy subjects.健康受试者中聚乙二醇化重组人粒细胞刺激因子的药代动力学/药效学建模
J Clin Pharmacol. 2006 Jul;46(7):747-57. doi: 10.1177/0091270006288731.